Blog

PACE® MULTIPLEX MASTER MIX (ENDPOINT) – USER GUIDE

PACE® Multiplex Master Mix (Endpoint) is a 2x PCR master mix for running two SNP or Indel genotyping assays in one reaction well, or for detecting a reference sequence plus up to three sequences of interest. This user guide covers reagent preparation, assay assembly for genotyping and sequence detection, reaction volumes for 96-, 384- and 1536-well formats, thermal cycling, four-colour fluorescence reading and data interpretation.

Looking for the trial kit instructions instead? See the PACE® Multiplex Master Mix Trial Kit user guide.

PACE Multiplex at a glance

  • Applications: two SNP or Indel genotyping assays in one well, or detection of a reference sequence and up to three targets of interest
  • Fluorophores: FAM, HEX, ATTO 590 and ATTO 647N, with ATTO 680 as passive reference dye
  • Pack sizes: 2.5 mL to 1,000 mL (500 to 200,000 reactions at 10 µL)
  • DNA input: 1-10 ng gDNA per well, purified or crudely extracted
  • Thermal cycling: 15 min activation at 94 °C, 10 touchdown cycles (65-57 °C), 30 cycles at 57 °C
  • Storage: -20 °C / -80 °C for two years, or 4 °C for two weeks protected from light

1. PRODUCT DETAILS

PACE® Multiplex Master Mix product table with part numbers 007-1001 to 007-1004, pack sizes from 2.5 mL to 1,000 mL (500 to 200,000 reactions at 10 µL), 2x concentration

2. DESCRIPTION

PACE Multiplex (PCR Allelic Competitive Extension) genotyping chemistry is a homogeneous, PCR-based allele-specific technology for the simultaneous analysis of two Single Nucleotide Polymorphisms (SNPs) or insertion/deletions (Indels), or detection of sequences of interest.

The PACE Multiplex chemistry is comprised of two parts:

  1. PACE Genotyping Assay: comprising two pairs of allele-specific forward primers and two common, reverse primers for SNPs or Indels, or four pairs of primers for detecting genes of interest.
  2. PACE Multiplex Master Mix: containing all components required for PCR and generation of fluorescent signals.

When combined and mixed with template DNA, these components create a PACE Multiplex Genotyping Reaction.

3. STORAGE AND SHELF LIFE

PACE Multiplex Master Mix is shipped on blue ice. Upon arrival, store at -20˚C/-80˚C (stable for two years); multiple freeze/thaw cycles are not recommended. PACE Multiplex Master Mix can be aliquoted into light-protective tubes to reduce the need for repeated freeze-thaw cycles. The mix can also be stored at 4˚C for two weeks (protected from light).

4. SAFETY WARNINGS AND PRECAUTIONS

This product should only be handled by trained laboratory personnel. It is advisable to wear suitable personal protective equipment (PPE) when using the product. In case of contact with skin or eyes, wash immediately with water.

5. KIT COMPONENTS

PACE Multiplex Master Mix (supplied at 2x concentration), containing a specifically engineered Taq polymerase, universal fluorescent reporting cassettes, dNTPs, buffer, performance enhancers, MgCl2 at 4.4 mM (2.2 mM at 1x concentration) and a passive reference dye, ATTO 680.

REQUIRED COMPONENTS

  • Fluorescent plate reader or qPCR machine capable of reading the fluorophores in Table 1
  • PCR plate or equivalent and appropriate optically clear seal
  • Template DNA
  • PCR-grade water
  • Genotyping assays (see section 8).
FLUOROPHOREEXCITATION (nm)EMISSION (nm)
FAM485520
HEX520560
ATTO 590590620
ATTO 647N649662
ATTO 680 Reference Dye681698
Table 1. Excitation and Emission values for the fluorophores used in the PACE Multiplex chemistry.

6. REFERENCE DYE

PACE Multiplex Master Mix is supplied with reference dye ATTO 680. Please check your instrument for reference dye compatibility; should you require further assistance, please contact the manufacturer of your qPCR instrument or plate reader or contact 3CR Bioscience’s Technical Support team.

7. MECHANISM OF ACTION

PACE Multiplex Master Mix uses a novel, universal, fluorescent reporting cassette to produce machine-readable fluorescent signal. The master mix contains four universal quenched fluorescent reporting cassettes, labelled with the fluorophores FAM, HEX, ATTO 590 and ATTO 647N.

When used for genotyping applications, two genotyping assays are used, each comprised of two competitive allele-specific forward primers (which differ in their terminal 3’ bases and unique 5’ tail sequences), and a common reverse primer. One multiplex assay reports with FAM and HEX, whilst the other reports with ATTO 590 and ATTO 647N.

When PCR is initiated, the allele-specific primers bind with their 3’ ends at the SNP of interest. Both allele-specific primers will bind if the SNP is heterozygous, whereas only one or other of the primers will bind if the SNP is homozygous. At the same time, the common reverse primer will bind on the opposite strand.

As PCR proceeds, the tail sequences of allele-specific forward primers become incorporated into the amplicon and the corresponding tail sequence complement is generated. At this point the quenched, fluorescent reporting cassettes bind to their appropriate tail sequence complements, becoming unquenched and producing a light signal. If the genotype of the SNP is homozygous, only one of the possible fluorescent signals will be generated, whereas if the SNP is heterozygous, the result will be a mixed fluorescent signal.

Alternatively, if PACE Multiplex Master Mix is used for sequence detection applications, one forward primer (containing a 5’ tail sequence, as for the allele-specific primers in the genotyping application above) can be designed to a reference sequence whilst the other three forward primers can be designed to individual targets of interest, with a reverse primer designed for each PCR. When testing for the presence or absence of sequences, the forward and reverse primers will bind, and the PCR will proceed as described above for a SNP.

The reference gene will always be present, so the assay will produce a homozygous fluorescent signal for the fluorophore selected for the reference sequence assay; this shows that the reaction is functioning as expected. The other assay primers will bind to their target sequences of interest (if present) and the appropriate signal(s) will be produced. If a gene of interest is present, both signals will be generated, resulting in a heterozygous sample.

8. MULTIPLEX ASSAYS

PACE Genotyping Assay designs are available free-of-charge by using our complimentary PACE Assay design service at www.3crbio.com or by contacting support@3crbio.com

A. GENOTYPING ASSAYS

PACE Multiplex Master Mix allows the use of two PACE Genotyping Assays simultaneously in one reaction well. Tables 2a and 2b show how to assemble assay mixes for PACE Genotyping Assays 1 and 2 from the constituent primers.

Pre-existing KASP™ and Amplifluor® assays (i.e., which contain allele-specific primers with FAM/HEX reporting tails) can also be used in conjunction with the PACE Multiplex genotyping chemistry. If used, these assays would replace those described in Table 2a.

PACE GENOTYPING ASSAY 1

PRIMERFINAL CONCENTRATION (µM)VOL. REQUIRED FOR 100 µL ASSAY MIX (µL)
Assay 1 allele-specific forward primer 1 – FAM sequence tail (100 µM)1212
Assay 1 allele-specific forward primer 2 – HEX sequence tail (100 µM)1212
Assay 1 common, reverse primer (100 µM)3030
PCR-grade water–46
TOTAL–100
Table 2a. Assembly of PACE Multiplex Genotyping Assay 1 (reporting with FAM and HEX).

PACE GENOTYPING ASSAY 2

PRIMERFINAL CONCENTRATION (µM)VOL. REQUIRED FOR 100 µL ASSAY MIX (µL)
Assay 2 allele-specific forward primer 1 – ATTO 590 sequence tail (100 µM)1212
Assay 2 allele-specific forward primer 2 – ATTO 647N sequence tail (100 µM)1212
Assay 2 common, reverse primer (100 µM)3030
PCR-grade water–46
TOTAL–100
Table 2b. Assembly of PACE Multiplex Genotyping Assay 2 (reporting with ATTO 590 and ATTO 647N).

B. SEQUENCE DETECTION ASSAYS

Table 3 shows how to assemble a PACE Genotyping Assay mix to detect multiple targets of interest.

Table for assembling a PACE® Multiplex sequence detection assay mix with HEX reference sequence and FAM, ATTO 590 and ATTO 647N targets: 6 µL forward and 15 µL reverse primer each, 16 µL water, 100 µL total
Table 3. Assembly of PACE Genotyping Assay mix for detection of a reference sequence and three sequences of interest. Note that the primer stocks are at 200 µM to allow requisite final primer concentrations.

9. DNA QUALITY AND QUANTITY

It is recommended to use 1-10 ng of gDNA per reaction well, though this will vary with organism genome size (large genomes will require a proportionately larger DNA mass). For optimal results, purified and well-normalised DNA samples should be used. However, when using PACE Multiplex Master Mix in high throughput, purified DNA is often not commercially practical. DNA that has been crudely extracted works well with PACE Multiplex Master Mix, but such samples should be tested before commencing large-scale work. Empirical optimisation of DNA concentration by testing a sample dilution range test is the most sensible approach. If DNA samples contain EDTA, the concentration at the final reaction concentration should be no higher than 0.1 mM.

10. CONTROLS

To improve confidence in the genotyping data, control samples should be used on the PCR plate in addition to the test samples. Negative controls (no-template controls, or NTCs) should always be used, and consist of the same buffer used to hydrate the DNA samples, dispensed into several wells of the PCR plate. Positive controls can also be used, if available, and should consist of DNA samples of known genotype.

When viewing the genotyping data, NTCs should show no amplification and remain around the origin of the cluster plot (see Figure 1), giving confidence that any amplification observed is real. Any amplification observed in the NTC wells would indicate contamination or non-specific amplification. The positive control samples should cluster in the expected regions for their genotype.

11. REACTION PROCEDURE

A. ARRAYING TEMPLATE DNA

A liquid-handling system appropriate to the number of DNA samples to array should be used. DNA samples can also be arrayed manually if working with a small number of samples.

PACE Multiplex Master Mix can be used with hydrated (Table 4a) or dry (Table 4b) DNA samples. Both approaches work equally well but have practical advantages and disadvantages. If low numbers of samples are to be genotyped, it is not worth drying the DNA samples. However, if high numbers of samples are to be genotyped in one run, drying the DNA samples can improve the resulting genotyping data. Hydrated DNA arrayed in a PCR plate will quickly begin to evaporate differentially across the plate (samples near the edges evaporate more quickly than those in the middle). Variation in DNA volumes across the plate will lead to variation in the final reaction concentrations, causing sub-optimal genotyping results. When drying the DNA into the plate wells the user must ensure that the DNA has been dried to completion. Dried DNA samples will be stable long term at ambient temperature. If a very small reaction volume is to be used (for example 1.0 µL total volume), it might not be possible to accurately dispense 0.5 µL of DNA and 0.5 µL of total reaction mix. In this example, drying the sample would allow a more realistic 1.0 µL of total reaction mix to be dispensed to the well. To dry the DNA, once dispensed into a PCR plate, the plate should be centrifuged to ensure the samples are in the bottom of the wells and placed in a laboratory fan oven for one hour at around 55˚C, or until the samples have visibly dried. When assembling the total reaction mix, water must be added in the correct proportion to account for the missing volume of the DNA template. See Tables 4a and 4b for details.

B. REACTION ASSEMBLY

PACE Multiplex Master Mix can be used with any reaction plate or well volume; it is not necessary to use a different product depending on reaction volume. It is very important that PACE Multiplex Master Mix is used at a final 1x concentration. However, the exception to this is in the PACE Genotyping Assay volumes shown in Tables 4a & 4b – the PACE Genotyping Assay volume is ignored as it does not cause any functionally meaningful dilution and does not affect the performance.

Table of PACE® Multiplex reagent volumes per well with hydrated DNA and two assays for a 96-well plate (10 µL), 384-well plate (5 µL) and 384-well array tape (1.6 µL)
Table 4a. Reagent assembly for PACE Multiplex Genotyping Reaction with hydrated DNA.
Table of PACE® Multiplex reagent volumes per well with dried DNA and two assays for 96-well (10 µL), 384-well (5 µL) and 1536-well (1 µL) plates and 384-well array tape (0.8 µL)
Table 4b. Reagent volumes for PACE Multiplex Genotyping Reaction with dried DNA.

If using PACE Multiplex Master Mix for sequence detection applications, just one PACE Genotyping Assay mix would be used so the ‘PACE Assay 2’ in Tables 4a & 4b would be ignored.

C. PACE MULTIPLEX GENOTYPING REACTION DISPENSING & PLATE SEALING

The total reaction mix must now be dispensed into the PCR plate wells. As with DNA dispensing, use a liquid handling system that is appropriate to the scale of the work. Once the total reaction mix has been dispensed, the PCR plate must be sealed with an optically clear seal and centrifuged to ensure all components are at the bottom of the wells.

D. THERMAL CYCLING

PACE Multiplex Genotyping Reactions should be thermally cycled according to the protocol in Table 5a.

PACE® Multiplex thermal cycling protocol: 94 °C for 15 min, 10 touchdown cycles from 65 °C to 57 °C, then 30 cycles of 94 °C and 57 °C
Table 5a. Thermal cycling conditions for PACE Multiplex Genotyping Reactions
PACE® Multiplex recycling protocol: 3 additional cycles of 94 °C for 20 seconds and 57 °C for 60 seconds
Table 5b. Thermal cycling conditions for recycling PACE Multiplex Genotyping Reactions.

E. FLUORESCENT SIGNAL DETECTION

After thermal cycling is complete, the fluorescent signal data should be collected using an appropriate fluorescent plate reader or qPCR machine in endpoint mode. Table 6 details the optimal suggested wavelength and bandwidth settings for each filter to minimise crosstalk between the different filters.

FLUOROPHOREEXCITATION (nm)EMISSION (nm)
FAM485 (10 nm)520 (10 nm)
HEX520 (10 nm)560 (10 nm)
ATTO 590590 (10 nm)620 (10 nm)
ATTO 647N635 (10 nm)670 (10 nm)
ATTO 680675 (10 nm)705 (10 nm)
Table 6. Suggested excitation and emission filter settings (with bandwidth in brackets) for the fluorophores used in the PACE Multiplex chemistry.

If the genotype clusters are not sufficiently defined after running the initial thermal cycling protocol, the plate should be cycled for an additional three cycles (see Table 5b) then the fluorescent signal data collected again. The additional cycling/data analysis can be repeated until tight and well-separated clusters are observed; however, it is recommended that this step is repeated a maximum of four times.

It is important that the fluorescent signal is read at or below 40˚C. If using a qPCR instrument, an additional temperature-controlled reading step should be included after the final PCR step or used separately to it. The temperature-controlled reading step should be used with both the main PCR (as described in Table 5a) and with any subsequent additional cycling steps (Table 5b). If using a fluorescent plate reader, the addition of this temperature-controlled reading step to the thermal cycling protocol should not be necessary as the PCR plate will have cooled sufficiently by the plate-reading stage.

F. INTERPRETATION OF DATA

The HEX, FAM, ATTO 590, and ATTO 647N fluorescence signal data produced by PACE Multiplex Genotyping Reactions should be analysed and interpreted as a cluster plot using cluster analysis software or with Microsoft Excel (see Figure 1).

ROX passive reference dye can also be used to eliminate the effect of well-to-well liquid volume differences from the resulting cluster plot data. The inclusion of a passive reference leads to tighter clustering and, as a result, more accurate scoring of data.

FAM versus HEX genotyping cluster plot from a PACE® Multiplex reaction with homozygous and heterozygous clusters and no-template controls at the origin
Figure 1. Diagram of typical genotyping cluster plot data generated from a PACE Multiplex Genotyping Reaction (only FAM/HEX plot shown). Black samples at the origin are the no-template controls (NTCs).

12. ORDERING INFORMATION

For ordering details, please visit www.3crbio.com.

13. SUPPORT

If you require any support with the use of PACE Multiplex Master Mix or other 3CR Bioscience products, please contact our Technical Support team on support@3crbio.com.

For Research Use Only. Not for use in diagnostic procedures.

3CR Bioscience disclaims all warranties with respect to this documentation.

The purchase of this product conveys to the purchaser the limited, non-transferable right to use the purchased amount of the product only to perform internal research for the sole benefit of the purchaser. No right to resell this product or any of its components is conveyed expressly or by implication. This product is for internal research purposes only and is not for use in commercial applications of any kind, including, without limitation, quality control and commercial services such as reporting the results of purchaser’s activities for a fee or other form of consideration.

KASP™ is a trademark of LGC Biosearch Technologies
Amplifluor® is a registered trademark of Merck KGaA


©2024 3CR Bioscience Ltd. All rights reserved. Intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.

MORE POSTS

PACE® 2.0 Genotyping Master Mix user guide shown on a tablet with the 3CR Bioscience logo
PACE® 2.0 GENOTYPING MASTER MIX – USER GUIDE
Running SNP or Indel genotyping with PACE® 2.0? This guide walks you through every step, from choosing the right ROX level and DNA input to reaction volumes, thermal cycling and reading your cluster plots, so you get tight, well-separated clusters first time.
PACE® Multiplex Master Mix (Endpoint) user guide shown on a tablet with the 3CR Bioscience logo
PACE® MULTIPLEX MASTER MIX (ENDPOINT) – USER GUIDE
Want to genotype two SNPs, or detect up to four targets, in a single well? This step-by-step guide shows you how to set up PACE® Multiplex Master Mix (Endpoint), from assay assembly and reaction volumes to thermal cycling, four-colour reading and clean cluster plots.
PACE® OneStep RT-PCR Master Mix user guide shown on a tablet with the 3CR Bioscience logo
PACE® ONESTEP RT-PCR MASTER MIX – USER GUIDE
Want reverse transcription and PCR in a single well? This step-by-step guide shows you how to set up PACE® OneStep RT-PCR Master Mix, from assay assembly and RNA handling to a 5 µL reaction, thermal cycling and clear cluster plots.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Resolve Genotyping Challenges. With One Practical Guide.

From failed amplification to scattered cluster plots — this guide provides structured, expert-backed solutions for the 7 most common PACE® genotyping issues.

"(Required)" indicates required fields

This field is for validation purposes and should be left unchanged.
I’d like to sign up for the newsletter

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager

For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.

Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.

Daniel LawsonMarketing Manager
Daniel is a strategically minded marketing and communications professional with over a decade of experience delivering integrated, multi-channel campaigns across healthcare, legal and not-for-profit sectors. He has a strong track record in building brand visibility, driving engagement and supporting revenue growth through audience-focused marketing.
Prior to joining 3CR Bioscience in 2025, Daniel held senior marketing roles where he led strategic communications, managed brand development and delivered high-impact digital and content campaigns. His experience spans SEO, CRM, PR, events and stakeholder engagement, with a particular strength in translating complex messages into clear, compelling content.
At 3CR Bioscience, Daniel is responsible for shaping and executing the company’s marketing strategy, enhancing brand presence and supporting commercial growth through targeted, data-driven campaigns.